erythromycin C

Term ID

CHEBI:64273

Synonyms

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
3''-O-Demethylerythromycin

Definition

An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.

References

cas:1675-02-1
kegg.compound:C06616
lipidmaps:LMPK04000009
metacyc.compound:CPD-13951
patent:US5476843
pubmed:15530995
pubmed:15870344
pubmed:4587460
pubmed:4995842
reaxys:75000

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from erythromycin C

Phenotype where environments contain erythromycin C

Phenotype modified by environments containing erythromycin C

Phenotype affecting erythromycin C

Human Disease Model